These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3776510)

  • 1. Ocular effects of treatment with various psoralen derivatives and ultraviolet-A (UVA) radiation in HRA/Skh hairless mice.
    Barker FM; Dayhaw-Barker P; Forbes PD; Davies RE
    Acta Ophthalmol (Copenh); 1986 Aug; 64(4):471-8. PubMed ID: 3776510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of 8-methoxypsoralen, 5-methoxypsoralen, 3-carbethoxypsoralen, or 5-methylisopsoralen with ultraviolet radiation in the hairless (HRA/Skh) mouse.
    Dunnick JK; Forbes PD; Davies RE; Iverson WO
    Toxicol Appl Pharmacol; 1987 Jun; 89(1):73-80. PubMed ID: 3590190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8-methoxypsoralen and long ultraviolet effects on the rat lens: experiments with high dosage.
    Koch HR; Beitzen R; Kremer F; Chioralia G; Baurmann H; Megaw J; Gardner K; Lerman S
    Graefes Arch Clin Exp Ophthalmol; 1982; 218(4):193-9. PubMed ID: 7084696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation.
    Dunnick JK; Forbes PD; Eustis SL; Hardisty JF; Goodman DG
    Fundam Appl Toxicol; 1991 Jan; 16(1):92-102. PubMed ID: 2019354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoralen-containing sunscreen is tumorigenic in hairless mice.
    Cartwright LE; Walter JF
    J Am Acad Dermatol; 1983 Jun; 8(6):830-6. PubMed ID: 6863646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, distribution, and excretion of 8-methoxypsoralen in HRA/Skh mice.
    Muni IA; Schneider FH; Olsson TA; King M
    Natl Cancer Inst Monogr; 1984 Dec; 66():85-90. PubMed ID: 6531044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect on topical 5-methoxypsoralen on tumorigenesis induced in albino and pigmented hairless mouse skin by UV irradiation.
    Reeve VE; Greenoak GE; Boehm-Wilcox C; Canfield PJ; Gallagher CH
    J Photochem Photobiol B; 1990 May; 5(3-4):343-57. PubMed ID: 2115915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary intake and risk assessment of phototoxic furocoumarins in humans.
    Schlatter J; Zimmerli B; Dick R; Panizzon R; Schlatter C
    Food Chem Toxicol; 1991 Aug; 29(8):523-30. PubMed ID: 1894218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation.
    Aubin F; Makki S; Humbert P; Muret P; Agache P
    Arch Dermatol Res; 1994; 286(1):30-4. PubMed ID: 8141609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoralen and ultraviolet A effects on epidermal ornithine decarboxylase induction and DNA synthesis in the hairless mouse.
    Lowe NJ; Connor MJ; Cheong ES; Akopiantz P; Breeding JH
    Natl Cancer Inst Monogr; 1984 Dec; 66():73-6. PubMed ID: 6531042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
    Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).
    Lambertini L; Surin K; Ton TV; Clayton N; Dunnick JK; Kim Y; Hong HH; Devereux TR; Sills RC
    Toxicol Pathol; 2005; 33(2):292-9. PubMed ID: 15902973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemotherapy using pyridopsoralens.
    Dubertret L; Averbeck D; Bisagni E; Moron J; Moustacchi E; Billardon C; Papadopoulo D; Nocentini S; Vigny P; Blais J
    Biochimie; 1985; 67(3-4):417-22. PubMed ID: 3899194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspects of psoralen phototumorigenesis with emphasis on the possible role of tumour promotion.
    Young AR
    Biochimie; 1986 Jun; 68(6):885-9. PubMed ID: 3019437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic effects of monofunctional and bifunctional furocoumarins.
    Mullen MP; Pathak MA; West JD; Harrist TJ; Dall'Acqua F
    Natl Cancer Inst Monogr; 1984 Dec; 66():205-10. PubMed ID: 6531030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular complications of PUVA therapy.
    See JA; Weller P
    Australas J Dermatol; 1993; 34(1):1-4. PubMed ID: 8240180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoralens and ocular effects in man and animals: in vivo monitoring of human ocular and cutaneous manifestations.
    Lerman S
    Natl Cancer Inst Monogr; 1984 Dec; 66():227-33. PubMed ID: 6531035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dietary omega-3 and omega-6 fatty acid sources on PUVA-induced cutaneous toxicity and tumorigenesis in the hairless mouse.
    Yen A; Black HS; Tschen J
    Arch Dermatol Res; 1994; 286(6):331-6. PubMed ID: 7979549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lens opacities appearing during therapy with methoxsalen and long-wavelength ultraviolet radiation.
    Lafond G; Roy PE; Grenier R
    Can J Ophthalmol; 1984 Jun; 19(4):173-5. PubMed ID: 6744101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sister-chromatid exchange induced by photoactivated 3-carbethoxypsoralen and 8-methoxypsoralen in human blood lymphocytes.
    Vijayalaxmi ; Wunder E
    Mutat Res; 1985; 152(2-3):211-5. PubMed ID: 4069147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.